Amplification and overexpression of the dual-specificity tyrosine-(Y)phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas

Cancer Research

Volumn 63, Issue 14, 2003, Pages 4136-4143

  Miller, Charles T ^a   Aggarwal, Sanjeev ^a   Lin, Theodore K ^a   Dagenais, Susan L ^a   Contreras, Jorge I ^a   Orringer, Mark B ^a   Glover, Thomas W ^a   Beer, David G ^a   Lin, Lin ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTIG; DNA; DUAL SPECIFICITY TYROSINE PHOSPHORYLATION KINASE 2; MESSENGER RNA; PHOSPHOTRANSFERASE; PROTEIN MDM2; UNCLASSIFIED DRUG;

AMPLICON; ARTICLE; BIOINFORMATICS; CARCINOGENESIS; CHROMOSOME 12; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MICROARRAY; ESOPHAGUS CARCINOMA; GENE AMPLIFICATION; GENE EXPRESSION; GENOME; HUMAN; HUMAN TISSUE; LOWER ESOPHAGUS SPHINCTER; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MARKER GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE TAGGED SITE;

ADENOCARCINOMA; CARDIA; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 12; ESOPHAGEAL NEOPLASMS; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RNA, MESSENGER;

EID: 0041672360     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Devesa, S. S., Blot, W. J., and Fraumeni, J. F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (Phila.), 83: 2049-2053, 1998.
2. Bollschweiler, E., Wolfgarten, E., Gutschow, C., and Hölscher, A. H. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer (Phila.), 92: 549-555, 2001.
3. Farrow, D. C., and Vaughan, T. L. Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States). Cancer Causes Control, 7: 322-327, 1996.
4. Sarr, M. G., Hamilton, S. R., Marrone, G. C., and Cameron, J. L. Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux. Am. J. Surg., 149: 187-193, 1985.
5. Jankowski, J. A., Wright, N. A., Meltzer, S. J., Triafilopoulos, G., Geboes, K., Casson, A. G., Kerr, D., and Young, L. S. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am. J. Pathol., 152: 965-973, 1999.
6. Lagergren, J., Bregstrom, R., Lindgren, A., and Nyren, O. N. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med., 340: 825-831, 1999.
7. Altorki, N. K., Oliveria, S., and Schrump, D. S. Epidemiology and molecular biology of Barrett's adenocarcinoma. Sem. Surg. Onc., 13: 270-280, 1997.
8. Hughes, S. J., Glover, T. W., Zhu, X. X., Kuick, R., Thoraval, D., Orringer, M. B., Beer, D. G., and Hanash, S. A novel amplicon at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma. Proc. Natl. Acad. Sci. USA, 95: 12410-12415, 1998.
9. Lin, L., Aggarwal, S., Glover, T. W., Orringer, M. B., Hanash, S., and Beer, D. G. A minimal critical region of the 8p22-23 amplicon in esophageal adenocarcinomas defined using sequence tagged site-amplification mapping and quantitative polymerase chain reaction includes the GATA-4 gene. Cancer Res., 60: 1341-1347, 2000.
10. Lin, L., Prescott, M. S., Zhu, Z., Singh, P., Chun, S. Y., Kuick, R. D., Hanash, S. M., Orringer, M. B., Glover, T. W., and Beer, D. G. Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon. Cancer Res., 60: 7021-7027, 2000.
11. Younes, M., Lebovitz, R. M., Lechago, L. V., and Lechago, J. p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study. Gastroenterology, 105: 1637-1642, 1993.
12. Hamelin, R., Flejou, J. F., Muzeau, F., Potet, F., Laurent-Puig, P., Fekete, F., and Thomas, G. TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus. Gastroenterology, 107: 1012-1018, 1994.
13. Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., and Vogelstein, B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (Lond.), 358: 80-83, 1992.
14. Leach, F. S., Tokino, T., Meltzer, P., Burrell, M., Oliner, J. D., Smith, S., Hill, D. E., Sidransky, D., Kinzler, K. W., and Vogelstein, B. p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res., 53: 2231-2234, 1993.
15. Soslow, R. A., Altorki, N. K., Yang, G., Xie, D., and Yang, C. S. mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma. Mod. Pathol., 12: 580-586, 1999.
16. Taniere, P., Martel-Planche, G., Maurici, D., Lombard-Bohas, C., Scoazec, J., Montesano, R., Berger, F., and Hainaut, P. Molecular and clinical differences between adenocarcinomas of the esophagus and of the gastric cardia. Am. J. Pathol., 158: 33-40, 2001.
17. Moskaluk, C. A., Hu, J., and Perlman, E. J. Comparative genomic hybridization of esophageal and gastroesophageal adenocarcinomas shows consensus areas of DNA gain and loss. Genes Chromosomes Cancer, 22: 305-311, 1998.
18. van Dekken, H., Geelen, E., Dinjens, W. N. M., Wijnhoven, B. P. L., Tilanus, H. W., Tanke, H. J., and Rosenberg, C. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32. I discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas. Cancer Res., 59: 748-752, 1999.
19. Mitchell, E. L., White, G. R., Santibanez-Koref, M. F., Varley, J. M., and Heighway, J. Mapping of gene loci in the Q13-Q15 region of chromosome 12. Chromosome Res., 3: 261-262, 1995.
20. Forus, A., Florenes, V. A., Maelandsmo, G. M., Meltzer, P. S., Fodstad, O., and Myklebost, O. Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2, Cell Growth Differ., 4: 1065-1070, 1993.
21. Nilbert, M., Rydholm, A., Mitelman, F., Meltzer, P. S., and Mandahl, N. Characterization of the 12q13-15 amplicon in soft tissue tumors. Cancer Genet. Cytogenet., 83: 32-36, 1995.
22. Reifenberger, G., Ichimura, K., Reifenberger, J., Elkahloun, A. G., Meltzer, P. S., and Collins, V. P. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Cancer Res., 56: 5141-5145, 1996.
23. Hatada, I., Hayashizaki, Y., Hirotsune, S., Komatsubara, H., and Mukai, T. A genomic scanning method for higher organisms using restriction sites as landmarks. Proc. Natl. Acad. Sci, USA, 88: 9523-9527, 1991.
24. Hirotsune, S., Hatada, I., Komatsubara, H., Nagai, H., Kuma, K., Kobayakawa, K., Kawara, T., Nakagawara, A., Fujii, K., Mukai, T., et al. New approach for detection of amplification in cancer DNA using restriction landmark genomic scanning. Cancer Res., 52: 3642-3647, 1992.
25. Rouillard, J. M., Erson, A. E., Kuick, R., Asakawa, J., Wimmer, K., Muleris, M., Petty, E. M., and Hanash, S. Virtual genome scan: a tool for restriction landmark-based scanning of the human genome. Genome Res., 11: 1453-1459, 2001.
26. Blin, N., and Stafford, D. W. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res., 3: 2303-2308, 1976.
27. Kuick, R., Asakawa, J., Neel, J. V., Satoh, C., and Hanash, S. M. High yield of restriction fragment length polymorphisms in two-dimensional separations of human genomic DNA. Genomics. 25: 345-353, 1995.
28. Kallioniemi, A., Kallioniemi, O-P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman. F., and Pinkel, D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (Wash. DC), 258: 818-821, 1992.
29. Giordano, T. J., Shedden, K. A., Schwartz, D. R., Kuick, R., Taylor, J. M., Lee, N., Misek, D. E., Greenson, J. K., Kardia, S. L., Beer, D. G., Rennert, G., Cho, K. R., Gruber, S. B., Fearon, E. R., and Hanash, S. Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am. J. Pathol., 159: 1231-1238, 2001.
30. Beer, D. G., Kardia. S. L., Huang, C. C., Giordano, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G., Thomas, D. G., Lizyness, M. L., Kuick, R., Hayasaka, S., Taylor, J. M., Iannettoni, M. D., Orringer, M. B., and Hanash, S. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med., 8: 816-824, 2002.
31. Thoraval, D., Asakawa, J., Wimmer, K., Kuick, R., Lamb, B., Richardson, B., Ambros, P., Glover, T., and Hanash, S. Demethylation of repetitive DNA sequences in neuroblastoma. Genes Chromosomes Cancer, 17: 234-244, 1996.
32. Costello, J. F., Fruhwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomaki, P., Lang, J. C., Schuller, D. E., Yu, L., Bloomfield, C. D., Caligiuri, M. A., Yates, A., Nishikawa, R., Su Huang, H., Petrelli, N. J., Zhang, X., O'Dorisio, M. S., Held, W. A., Cavenee, W. K., and Plass, C. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet., 24: 132-138, 2000.
33. Reifenberger, G., Liu, L., Ichimura, K., Schmidt, E. E., and Collins, V. P. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res., 53: 2736-2739, 1993.
34. Esteve, A., Lehman, T., Jiang, W., Weinstein, I. B., Harris, C. C., Ruol, A., Peracchia, A., Montesano, R., and Hollstein, M. Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human esophageal carcinomas. Mol. Carcinog., 8: 306-311, 1993.
35. Kovar, H., Auinger, A., Jug, G., Aryee, D., Zoubek, A., Salzer-Kuntschik, M., and Gadner, H. Narrow spectrum of infrequent p53 mutations and absence of MDM2 amplification in Ewing tumours. Oncogene, 8: 2683-2690, 1993.
36. Kessis, T. D., Slebos, R. J., Han, S. M., Shah, K., Bosch, X. F., Munoz, N., Hedrick, L., and Cho, K. R. p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix. Am. J. Pathol., 143: 1398-1405, 1993.
37. Quesnel, B., Preudhomme, C., Fournier, J., Fenaux, P., and Peyrat, J. P. MDM2 gene amplification in human breast cancer. Eur. J. Cancer, 30A: 982-984, 1994.
38. Ohnishi, H., Kawamura, M., Hanada, R., Kaneko, Y., Tsunoda, Y., Hongo, T., Bessho, F., Yokomori, K., and Hayashi, Y. Infrequent mutations of the TP53 gene and no amplification of the MDM2 gene in hepatoblastomas. Genes Chromosomes Cancer, 15: 187-190, 1996.
39. Tejedor, F., Zhu, X. R., Kaltenbach, E., Ackermann, A., Baumann, A., Canal, I., Heisenberg, M., Fischbach, K. F., and Pongs, O. minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila. Neuron, 14: 287-301, 1995.
40. van Es, S., Weening, K. E., and Devreotes, P. N. The protein kinase YakA regulates g-protein-linked signaling responses during growth and development of Dictyostelium. J. Biol. Chem., 276: 30761-30765, 2001.
41. Becker, W., Weber, Y., Wetzel, K., Eirmbter, K., Tejedor, F. J., and Joost, H. G. Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases. J. Biol. Chem., 273: 25893-25902, 1998.
42. Song, W. J., Sternberg, L. R., Kasten-Sportes, C., Keuren, M. L., Chung, S. H., Slack, A. C., Miller, D. E., Glover, T. W., Chiang, P. W., Lou, L., and Kurnit, D. M. Isolation of human and murine homologues of the Drosophila minibrain gene: human homologue maps to 21q22.2 in the Down syndrome "critical region." Genomics, 38: 331-339, 1996.
43. Chen, H., and Antonarakis, S. E. Localisation of a human homologue of the Drosophila mnb and rat Dyrk genes to chromosome 21q22.2. Hum. Genet., 99: 262-265, 1997.
44. Miyata, Y., and Nishida, E. Distantly related cousins of MAP kinase: biochemical properties and possible physiological functions. Biochem. Biophys. Res. Commun., 266: 291-295, 1999.
45. Smith, D. J., Stevens, M. E., Sudanagunta, S. P., Bronson, R. T., Makhinson, M., Watabe, A. M., O'Dell, T. J., Fung, J., Weier, H. U., Cheng, J. F., and Rubin, E. M. Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nat. Genet., 16: 28-36, 1997.
46. Okui, M., Ide, T., Morita, K., Funakoshi, E., Ito, F., Ogita, K., Yoneda, Y., Kudoh, J., and Shimizu, N. High-level expression of the Mnb/Dyrk1A gene in brain and heart during rat early development. Genomics, 62: 165-171, 1999.
47. Rahmani, Z., Lopes, C., Rachidi, M., and Delabar, J. M. Expression of the nmb (dyrk) protein in adult and embryonic mouse tissues. Biochem. Biophys. Res. Commun., 253: 514-518, 1998.
48. Woods, Y. L., Rena, G., Morrice, N., Barthel, A., Becker, W., Guo, S., Unterman, T. G., and Cohen, P. The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site. Biochem. J., 355: 597-607, 2001.
49. Matsuo, R., Ochiai, W., Nakashima, K., and Taga, T. A new expression cloning strategy for isolation of substrate-specific kinases by using phosphorylation site-specific antibody. J. Immunol. Methods., 247: 141-151, 2001.
50. Mao, J., Maye, P., Kogerman, P., Tejedor, F. J., Toftgard, R., Xie, W., Wu, G., and Wu, D. Regulation of Gli 1 transcriptional activity in the nucleus by Dyrk1. J. Biol. Chem., 277: 35156-35161, 2002.
51. Lee, J., Platt, K. A., Censullo, P., and Ruiz i Altaba, A. Gli1 is a target of sonic hedgehog that induces ventral neural tube development. Development, 124: 2537-2552, 1997.
52. Dahmane, N., Lee, J., Robins, P., Heller, P., and Ruiz i Altaba. A. Activation of the transcription factor gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature (Lond.), 389: 876-881, 1997.
53. Lee, K., Deng, X., and Friedman, E. Mirk protein kinase is a mitogen-activated protein kinase substrate that mediates survival of colon cancer cells. Cancer Res., 60: 3631-3637, 2000.
54. Park, G. H., Choe, J., Choo, H. J., Park, Y. G., Sohn, J., and Kim, M. K. Genome-wide expression profiling of 8-chloroadenosine- and 8-chloro-cAMP-treated human neuroblastoma cells using radioactive human cDNA microarray. Exp. Mol. Med., 34: 184-193, 2002.